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Abstract The control of proliferation and differentiation by tumor suppressor genes suggests
that evolution of divergent tumor suppressor repertoires could influence species’ regenerative
capacity. To directly test that premise, we humanized the zebrafish p53 pathway by introducing
regulatory and coding sequences of the human tumor suppressor ARF into the zebrafish genome.
ARF was dormant during development, in uninjured adult fins, and during wound healing, but was
highly expressed in the blastema during epimorphic fin regeneration after amputation.
Regenerative, but not developmental signals resulted in binding of zebrafish E2f to the human ARF
promoter and activated conserved ARF-dependent Tp53 functions. The context-dependent
activation of ARF did not affect growth and development but inhibited regeneration, an
unexpected distinct tumor suppressor response to regenerative versus developmental
environments. The antagonistic pleiotropic characteristics of ARF as both tumor and regeneration
suppressor imply that inducing epimorphic regeneration clinically would require modulation of ARF
–p53 axis activation.
DOI: 10.7554/eLife.07702.001
Introduction
Urodele amphibians and teleost fish are unique among vertebrates in that they possess the ability to
regenerate injured complex structures such as limbs, fins, jaws, and heart by epimorphic regenera-
tion (Morgan, 1901; Brockes and Kumar, 2008; Poss, 2010). For example, zebrafish fin regenera-
tion proceeds through steps that include wound healing, blastema formation, and regenerative
outgrowth to faithfully restore preinjury structures and size of the fin (Poss et al., 2003). In such
highly regenerative species, the blastema consists of a heterogeneous pool of highly proliferative
mesenchymal cells that gives rise to the large amount of new tissue in the regenerate (Knopf et al.,
2011; Tu and Johnson, 2011). In contrast, absence of a proliferative blastema is a prominent feature
of most mammalian solid tissue injury responses (Muneoka et al., 2008; Straube and Tanaka,
2006). An open question in biology is how cellular mechanisms controlling proliferation affect the
blastema and whether they have evolved to contribute to divergent regenerative capacities among
vertebrate species.
Tumor suppressor genes control the proliferative and differentiated state of cells, and many are
also developmental regulators critical for normal formation of tissues (Jacks et al., 1992;
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Berman et al., 2008). The complex and precisely controlled proliferation and differentiation that
occurs during epimorphic regeneration likely requires similar machinery, and as a group, tumor sup-
pressors are probably necessary for well-orchestrated regeneration to occur (Pomerantz and Blau,
2013). For example, in eukaryotes the retinoblastoma gene Rb1 regulates the G1/S transition by
sequestering E2f transcription factors, and it controls cellular differentiation by associating with chro-
matin modifiers to regulate activity of tissue-specific transcription factors. Therefore, the role of Rb1
in tumor suppression is likely less important from an evolutionary standpoint than its ancient broad
functions in regulating cellular differentiation and tissue formation. In contrast, the mammalian gene
Cdkn2a is an essential tumor suppressor in mice and humans, but it is dispensable for mammalian
development and tissue formation (Serrano et al., 1996). In mammals, Cdkn2a encodes two struc-
turally unrelated proteins translated via alternate reading frames, p16Ink4a and Arf, each of which is
a tumor suppressor (Chin et al., 1998; Sherr, 2006). While p16Ink4a is a cyclin-dependent kinase
inhibitor (CKI) that functions upstream of Rb1, Arf exerts its tumor suppressor function by respond-
ing to inappropriate Rb pathway signaling above a presumed threshold (Lowe and Sherr, 2003).
When induced, it stabilizes and activates Tp53 by binding and sequestering Mdm2, an E3 ubiquitin
ligase and negative regulator of Tp53 (Pomerantz et al., 1998; Weber et al., 1999). Depending on
the context, stabilized Tp53 either promotes cell cycle arrest or apoptosis. In addition to canonical
Tp53-dependent functions, Arf has other important functions including controlling ribosome biogen-
esis and responding to oxidative stress (Sherr, 2006; Weber et al., 2000; Damalas et al., 2011;
Menendez et al., 2003). The resulting general function of Arf is to maintain the postmitotic state,
and we have previously shown that suppression of Arf in the context of compromise of the Rb path-
way results in dedifferentiation and proliferation of mammalian muscle cells in culture (Pajcini et al.,
2010). Unlike in development or in regeneration of epithelial and hematopoietic tissues, reversal of
the postmitotic state and dedifferentiation also occur in lower vertebrate epimorphic regeneration
scenarios that involve a blastema. Regulation of Tp53 has recently been shown to be important dur-
ing epimorphic regeneration, where it is downregulated during blastema formation (Yun et al.,
2013). Although cell cycle reentry of postmitotic cells and dedifferentiation are characteristics of
malignant transformation which tumor suppressor mechanisms oppose, why these two processes are
permitted to occur in the context of intact tumor suppressor mechanisms during epimorphic regen-
eration is unknown.
How evolution of the central cellular growth and tumor suppressor pathways impacts regenera-
tive capacity is poorly understood. The advent of somatic stem cells in metazoans is thought to have
eLife digest Zebrafish are capable of remarkable feats of regeneration in which damaged or
lost body parts can be replaced with exact replicas of the original. Humans cannot do this; so one
major goal of regenerative medicine is to understand the basis of these differences. This could make
it possible to regenerate damaged limbs, heart muscle and other tissues in people.
A group of genes called tumor suppressor genes are critical for protecting us from cancer.
However, they also limit the ability of cells to grow and divide, which are both important for
regeneration processes. Differences in how organisms use tumor suppressor genes could possibly
contribute to their differing abilities to regenerate body parts.
A tumor suppressor gene called ARF plays an important role in protecting mammals from cancer,
but it is not found in zebrafish and other animals that can regenerate body parts. Hesse et al.
introduced the human ARF gene into zebrafish to investigate whether it has any effect on tissue
regeneration. The experiments show that ARF is silent in growing and uninjured fish, but it is
activated when it detects regeneration occurring after an injury. ARF drastically inhibits this process
to the point that fish with the ARF gene cannot regenerate damaged tissue. The findings suggest
that ARF mistakenly identifies regeneration as the formation of a tumor; therefore therapies that aim
to induce regeneration in people may need to control the activity of this gene.
Hesse et al.’s findings show that the specific tumor suppressor genes an organism has can affect
its ability to regenerate. Future challenges will be to understand the situations in which ARF is able
to interfere with tissue regeneration in mammals, and to learn how to manipulate this process.
DOI: 10.7554/eLife.07702.002
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enabled the formation of new types of cancer, thus requiring advanced tumor suppressor mecha-
nisms (Belyi et al., 2010; Pearson and Sanchez Alvarado, 2008). Among metazoan species, includ-
ing vertebrates, selective pressures such as different physiologies and environmental exposures
undoubtedly continue to apply pressure to generate species-specific tumor suppressor repertoires.
For some tumor suppressor genes such as Tp53, multiple family members have evolved to carry out
certain differentiation functions separately from tumor suppression. For others, such as Arf, a single
member has evolved and exists in a limited number of species. Whether such differences in turn
relate to distinct regenerative capacities remains unknown.
Although tumor suppressors are generally highly conserved in eukaryotes, Arf is unusual in that it
is poorly conserved in non-mammalian lineages (Figure 1A). The Cdkn2a/b locus of teleost fish,
including zebrafish (Danio rerio) and fugu (Takifugu rubripes) (Gilley and Fried, 2001), exists as a
single protein-producing unit that only encodes for a CKI. During evolution, Cdkn2a and Cdkn2b
developed into two separate but related genes encoding for biochemically related CKIs. Arf is not a
CKI and is not closely related to either Cdkn2a or Cdkn2b. Arf is thought to be the product of a
genetic duplication caused by either an insertion or transposition into the Cdkn2a/b locus (Gil and
Peters, 2006). Of the highly regenerative species for which genomes have been completely
sequenced, none possess an ortholog of Arf (Figure 1A) (Flicek et al., 2014; Karolchik et al.,
2014). The earliest documented ortholog of Arf exists in the chicken genome (Kim et al., 2003).
This restricted representation coupled with ARF functions of responding to a high threshold of prolif-
erative signaling and inhibiting dedifferentiation (Pajcini et al., 2010; Sherr, 2006) is compatible
with a hypothesis that the presence of Arf could impact regenerative capacity.
In this study, we used transgenesis to examine the activity of human ARF in the context of zebra-
fish fin regeneration. We showed that ARF activated zebrafish Tp53 functions to restrict cellular pro-
liferation and induced apoptosis, which caused a marked suppression of fin regeneration after injury.
Remarkably, the human ARF regulatory sequences are dormant throughout zebrafish development
but induce ARF expression specifically during regeneration after injury. These findings provide
experimental evidence that species-specific tumor suppressors can impact tissue regeneration
potential.
Results
Survey of ARF orthologs in genomes of highly and poorly regenerative
vertebrates
Using the Ensembl Genome Browser (Flicek et al., 2014), the University of California, Santa Cruz
(UCSC) Genome Browser (Karolchik et al., 2014), and Sal-Site (Smith et al., 2005), we analyzed the
Ink4b-Arf-Ink4a locus in the genomes of six different vertebrate species including highly regenerative
(teleost fish and urodele amphibians) and poorly regenerative (avians and mammals) vertebrates
(Monaghan and Maden, 2013). Our analysis confirms prior reports (Kim et al., 2003) that an ARF
ancestor exists in chickens. We found that in contrast to Ink4 orthologs, which are pervasive through-
out vertebrate genomes, ARF orthologs are not present in the genomes of highly regenerative ver-
tebrates (Figure 1A). The results of this analysis, while not directly demonstrating an association of
ARF with regeneration, support the hypothesis and prompted our investigation.
Context-specific activation of ARF by regenerative signals in the
zebrafish blastema
To investigate how the ARF gene responds to environmental cues, we generated reporter fish in
which green fluorescent protein (GFP) is expressed under the control of the human ARF promoter
(Tg (ARF:GFP) or ARF:GFP) (Figure 1B, top). In mammals, ARF expression is regulated by a pro-
moter that contains several putative E2F binding sites, and ARF expression can be regulated by free
E2F levels above a threshold (Gil and Peters, 2006). The ARF promoter has previously been empiri-
cally defined (del Arroyo et al., 2007) and no other regulatory sequences or enhancers have been
described to date. We first confirmed that the human ARF promoter can function in zebrafish cells in
vitro in transfection experiments using previously described firefly luciferase reporter constructs
(del Arroyo et al., 2007). Experiments were performed with ZF4 and zebrafish kidney stromal (ZKS)
(Stachura et al., 2009) cells with HeLa cells used as a positive control since they express high levels
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Figure 1. ARF, not normally present in highly regenerative vertebrates, is specifically activated in blastemas of ARF transgenic zebrafish. (A)
Comparison of amino acid sequences of proteins produced by the Cdkn2a/b loci of zebrafish (Danio rerio), amphibians including the axolotl
(Ambystoma mexicanum) and western clawed frog (Xenopus tropicalis), chickens (Gallus gallus), and mammals including the mouse (Mus musculus) and
human (Homo sapiens). While Cdkn2a and Cdkn2b are conserved and encode Ink4 orthologs, Arf evolved recently and orthologs do not exist in highly
regenerative vertebrates including teleost fish and urodele amphibians. (B) Schematic of transgene expressing cytoplasmic Green fluorescent
protein (GFP) under the control of the human ARF promoter (top). The promoter consists of human regulatory sequences 736 bp upstream of the
transcriptional start site (TSS) of ARF. Immunostaining (wide-field images) for GFP at 24 hpf, 48 hpf, and 72 hpf in wild type (WT) and ARF:GFP embryos
(bottom). Scale bars: 200 mm. GFP expression is visible in the hearts of transgenic fish due to presence of a separate transgene used for selection
(cmlc2:GFP). (C) Whole-mount in situ hybridization for GFP at 24 hpf, 48 hpf, and 72 hpf in WT and ARF:GFP embryos. Scale bars: 100 mm. Alkaline
phosphatase staining is detected in the hearts of transgenic fish (arrow heads) because of the selection transgene as in (B). (D) Confocal images of
coronal vibratome sections immunostained for GFP, Msxb, and Proliferating cell nuclear antigen (PCNA) at 2 dpa in WT and ARF:GFP fins. Scale bars:
50 mm. GFP expression is induced in the proliferative blastema of the regenerate, but it is not expressed in the surrounding epithelium. White dashed
lines represent amputation planes. (E) GFP intensity (green line) in the regenerates of ARF:GFP transgenic fish relative to WT fish after amputation. The
Figure 1. continued on next page
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of endogenous ARF (Figure 1—figure supplement 1). These assays confirmed that the 736 base
pair (bp) promoter is active in HeLa cells and in zebrafish lines. Therefore, we chose the 736 bp
genomic fragment encompassing the human ARF promoter to generate ARF transgenics that mimic
regulation of the human ARF gene. Tol2-mediated transgenesis (Kwan et al., 2007) was used to
generate ARF:GFP fish, and transgenic fish were detected using cardiac GFP expression driven by a
separate cmlc2:GFP cassette on the transgene.
We monitored expression of GFP driven by the human ARF promoter during normal develop-
ment and in adult fish after injury and during regeneration. To determine if ARF:GFP is active during
organogenesis in the zebrafish embryo, we assayed GFP expression at three developmental time
points, 24, 48, and 72 hr postfertilization (hpf). We were unable to detect ARF:GFP expression in the
embryo head, body, or tail by wide field epi or confocal immunofluorescence indicating that the
ARF promoter is silent at these developmental stages (Figure 1B, Figure 1—figure supplement
2A). GFP expression in the heart driven by the cmlc2 promoter serves as an internal control. To con-
firm that our analysis was not significantly compromised by limits of detection, we also performed in
situ hybridization for GFP transcripts (Figure 1C). The in situ hybridization results confirmed the
immunofluorescence analysis and indicate that ARF is silent or minimally expressed during develop-
ment, including the developing tail fin region.
To investigate ARF activation during regeneration, ARF:GFP regenerates were assessed at the
time of amputation and then at time points during which wound healing, blastema formation, and
outgrowth of regenerating fins occurs (Poss et al., 2003). ARF:GFP transgenic fish regenerated their
fins normally. In stark contrast to development, ARF:GFP was induced and highly expressed in the
blastema of regenerating adult fins. GFP was specifically detected in ARF:GFP fins after amputation,
and GFP colocalized with Msxb and proliferating cell nuclear antigen (PCNA) expressing cells
(Figure 1D, Figure 1—figure supplement 2B). GFP was not detected in the surrounding epithelium.
This observation indicates that the ARF promoter is active in at least a subset of Msxb + blastema
cells. GFP signal in the regenerate was first detected at 12 hr postamputation (hpa), peaked at 48
hpa, and then declined to undetectable levels within 6 days (Figure 1E, Figure 1—figure supple-
ment 2C). To correlate GFP expression with proliferation in ARF:GFP fins, we assessed EdU incorpo-
ration in regenerates at the above time points. There is a low level of proliferation in uninjured fins
(0 hpa), but proliferation quickly increases to maximal levels within 48 hpa and then decreases
(Figure 1E). GFP expression mirrored proliferative changes, suggesting that ARF detects and
responds to high proliferative signaling in the regenerate.
To further examine the specificity of ARF regulation, we examined the response to the creation of
an epithelial laceration wound. In this interray wound model, healing occurs without regeneration or
blastema formation (Gauron et al., 2013). An epithelial wound was created in the dorsal fin lobe
(Figure 1—figure supplement 3A) and the ventral fin lobe of the same fish was amputated. GFP
expression was evaluated 1 day postinjury (dpi) (Figure 1—figure supplement 3B). As expected,
GFP was detected in the forming ventral blastema. However, GFP was undetectable in the healing
wound. These distinct ARF responses to development and to the two different forms of injury indi-
cate that ARF specifically senses and responds to signals particular to the regeneration environment
that differ significantly from those present during wound healing or in the highly proliferative envi-
ronment of developmental organogenesis.
Figure 1. Continued
black line represents the percentage of EdU + cells in the regenerates of WT fish after amputation (N=3; secondary axis). Figure supplement 1 shows in
vitro ARF promoter assays. Figure supplement 2 shows additional images for panels B, D, and E. Figure supplement 3 shows wound healing in WT and
ARF:GFP fins. Results are shown as mean ± standard deviation. hpa: Hours post amputation.
DOI: 10.7554/eLife.07702.003
The following figure supplements are available for Figure 1:
Figure supplement 1. In vitro analysis of ARF promoter constructs in zebrafish and human cells.
DOI: 10.7554/eLife.07702.004
Figure supplement 2. GFP reporter activity in WT or ARF:GFP zebrafish at multiple developmental and regenerative time points.
DOI: 10.7554/eLife.07702.005
Figure supplement 3. ARF is not activated during wound healing in the absence of a blastema.
DOI: 10.7554/eLife.07702.006
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Figure 2. Rb1 hyperphosphorylation and E2f1 binding of the human ARF promoter in the blastema during
regeneration. (A) Representative Western blot of three experimental replicates of Rb pathway components, E2f1,
Rb1, and hyperphosphorylated Rb1 (p-Rb1), before injury (uninj.), at 2 dpa, and during embryogenesis at 72 hpf
(left). Quantification of p-Rb1 and Rb1 levels normalized to b-Actin and relative to uninjured tissue. Results are
from three independent biological replicate experiments and are shown as mean ratios ± standard deviation.
*p<0.05; ***p<0.001 (right). (B) Confocal images of coronal vibratome sections immunostained for Green
fluorescent protein (GFP), Msxb, and p-Rb1 in uninjured and regenerating (2 dpa) ARF:GFP fins. Scale bars: 50 mm.
Very little p-Rb1 staining is seen in the uninjured fin, but high levels of p-Rb1 staining can be seen in Msxb + cells
in the blastema at 2 dpa. The white dashed line represents the amputation plane. (C) Representative ChIP qPCR
data of three experimental replicates with a pool of 30 fins per experiment. Tissue was collected from ARF:GFP
transgenic fish before injury (uninj.), at 2 dpa (regenerate only), and at 72 hpf. Fold enrichment of E2f1 binding was
normalized to rabbit IgG. The zebrafish thymidine kinase 1 (tk1) promoter was used as a positive control for E2f1
binding. Sequences 2 kbp upstream of tk1 were used as a negative control (tk1-). Values above twofold (black
Figure 2. continued on next page
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Zebrafish E2f1 binds the human ARF promoter specifically in the
context of Rb hyperphosphorylation during regeneration
In mammalian cells, ARF detects and responds to aberrant inhibition of the Rb pathway (Sharp-
less, 2005; Sherr, 2006). To investigate the specific factors that activate ARF during zebrafish fin
regeneration, but not during development, we assessed Rb pathway inhibition by Western blot anal-
ysis of E2f1, Rb1, and hyperphosophorylated-Rb1 (p-Rb1) in developing embryos (72 hpf), in adult
uninjured fin tissue (uninj.) and at 2 days postamputation (dpa). Whereas p-Rb1 levels were relatively
low in uninjured adult fins, a modest increase was detected in 72 hpf embryos. However, 2 dpa
regenerates contained a dramatic increase in p-Rb1 levels despite stable levels of total Rb1 and total
E2f1 (Figure 2A). This reflects a high level of pro-proliferation signaling resulting in inactivation of
Rb1 by phosphorylation, as occurs commonly in tumors. To further investigate where in the regener-
ating fin the changes in p-Rb1 phosphorylation occurred, immunostaining of regenerating and unin-
jured fins was performed. Similar to Western blot analysis, immunostaining revealed a dramatic
increase in p-Rb1 staining during regeneration (Figure 2B). A small amount of p-Rb1 staining was
observed in uninjured fins, which is most likely the result of homeostatic proliferation (Wills et al.,
2008). Co-immunostaining for GFP, and Msxb confirmed that p-Rb1 hyperphosphorylation and GFP
were co-expressed in cells specifically localized within the blastema.
The hyperphosphorylation of Rb1 in the blastema suggested that resulting elevated levels of free
E2f could be sensed by ARF resulting in transcriptional activation. Moreover, since E2F can directly
activate ARF in mammals (Gil and Peters, 2006), we evaluated interaction of fish E2f1 with the
mammalian ARF promoter by chromatin immunoprecipitation (ChIP) experiments using an anti-E2f1
antibody in developing ARF:GFP embryos and uninjured and 2 dpa ARF:GFP fins. We analyzed the
precipitated DNA fragments by quantitative polymerase chain reaction (qPCR) for three specific
genomic regions, the ARF promoter, the tk1 promoter (a known target gene of E2f1; Wells et al.,
2002), and a region 2 kilobases (kb) upstream of the tk1 promoter (tk1-) as a negative control (Fig-
ure 2—figure supplement 1). We found that in contrast to the state before amputation, ARF is
bound by E2f1 specifically during regeneration as is tk1 but not tk1- (Figure 2C). The ChIP assay
showed that binding of the ARF promoter by E2f1 was enriched over sixfold relative to non-ampu-
tated controls and the tk1- control. The ARF promoter was even more highly enriched than the tk1+
control. Despite the modestly increased p-Rb1 levels in 72 hpf embryos, which correlated with
enrichment of E2f1 at the tk1 promoter, no increase in E2f1 binding of the ARF promoter was
observed. This finding suggests that the ARF promoter responds strongly and specifically to supra-
threshold free E2f1 levels present during regeneration as opposed to other physiological contexts.
This result implies that proliferative signaling during fin regeneration has similarities to that during
mammalian tumor formation which elicit the ARF tumor suppressor response.
Human ARF suppresses zebrafish fin regeneration
Since ARF is a human protein with no orthologs in zebrafish, we confirmed the expected subcellular
localization of ARF and stabilization of Tp53 in zebrafish cells in vitro using the zebrafish cell lines,
ZF4 and ZKS (Stachura et al., 2009). Cells were transfected with an ARF expression construct
(human ARF cDNA subcloned into pcDNA3) to determine the subcellular localization of the protein
as well as to confirm its interactions with orthologs of its mammalian partner, Mdm2 (Sherr, 2006;
Sharpless, 2005). Confocal imaging showed that human ARF localized to the nucleolus and co-local-
ized with Mdm2 in zebrafish cells (Figure 3—figure supplement 1A). Tp53 levels were examined in
fish cells transfected with ARF expression or control constructs. Elevated Tp53 levels were readily
observed in approximately 40% of ARF transfected cells (Figure 3—figure supplement 1A,B). The
Figure 2. Continued
dashed line) are significant (p<0.05). Figure supplement 1 shows promoter sequences for the ARF, tk1, and tk1-
promoters annotated for canonical E2f binding sites. hpa: Hours postamputation.
DOI: 10.7554/eLife.07702.007
The following figure supplements are available for Figure 2:
Figure supplement 1. Promoter sequences evaluated for E2f1 enrichment using an E2f1 antibody to perform a
ChIP assay.
DOI: 10.7554/eLife.07702.008
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Figure 3. Expression of the mammalian tumor suppressor ARF in zebrafish driven by heat shock promoter. In
vivo analysis of transgenic zebrafish expressing human ARF under the control of an inducible heat shock promoter,
Tg (hsp70l:ARF) (hs:ARF). Schematic of the hs:ARF transgene (top left). The ARF cassette included in the transgene
is a cDNA that consists of human exons 1b, 2, and 3 of CDKN2A. Representative Western blot of 3 replicates of
ARF before (0 hr) and 3 and 6 hr post heat shock induction of ARF expression (top middle). Portion of fin shown
for analysis of expression in vivo (top right; dashed box). Scale bar: 1 mm. Immunostaining (sagittal confocal
images) for ARF in adult hs:ARF zebrafish fins at 0, 3, and 8 hr after a single, hour long, 37˚C heat shock (bottom).
Scale bars: 50 mm. ARF expression is maximal at 3 hr post heat shock, and it is undetectable by 8 hr post heat
shock. Figure supplement 1 shows in vitro assays.
DOI: 10.7554/eLife.07702.009
The following figure supplements are available for Figure 3:
Figure supplement 1. Analysis of ARF expression in zebrafish cells.
DOI: 10.7554/eLife.07702.010
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recapitulation of typical localization and Tp53 upregulation suggested conservation of human ARF
functions in zebrafish cells and supported investigation of ARF transgenic fish. To investigate the
phenotypic effects of ARF on regeneration in vivo, we first utilized the heat shock protein 70 induc-
ible promoter to drive expression of ARF (Tg (hsp70l:ARF) or hs:ARF) (Figure 3). hs:ARF fish were
subjected to multiple heat shock regimens to determine ARF expression and stability. Immunostain-
ing showed that when induced with an hour long, 37˚C heat shock, ARF is robustly expressed in the
fin 3 hr later (Figure 3). Western blot confirmed induction of ARF protein expression and also
showed a rapid decrease almost to baseline at 6 hr (Figure 3), in accordance with the known 6 hr
half-life of the human protein (Sherr, 2006).
We then examined the effects of inducible, transient ARF expression on fin regeneration. Using a
regimen of one heat shock 3 hr prior to amputation and then subsequently every 6 hrs up to 6 dpa
(Figure 4A, top), fin regeneration in hs:ARF transgenic fish was compared with non-transgenic wild
type (WT) clutchmates. hs:ARF and WT fish tolerated heat shock well without overt illness or mortal-
ity. ARF expression caused significant inhibition of fin regeneration as evidenced by reduced regen-
erate length and area; WT regenerates measured 1.2 ± 0.13 mm in length and 5.4 ± 1.3 mm2 in area
compared with hs:ARF regenerates, which measured 0.84 ± 0.13 mm in length and 3.0 ± 0.76 mm2
in area, a reduction of approximately 30% (p<0.001) and 45% (p<0.001), respectively (Figure 4B).
Inducible ARF expression was confirmed in hs:ARF, but not WT fins exposed to heat shock during
regeneration (4 dpa) (Figure 4—figure supplement 1A). After the heat shock regimen ended, fin
regeneration resumed to reach full length by 14 dpa (Figure 4—figure supplement 1B). Both hs:
ARF transgenic fish maintained at 28–30˚C and WT fish exposed to heat shock regenerated their fins
normally. When previously heat-shocked hs:ARF fins were reamputated and allowed to regenerate
in the absence of heat shock (Figure 4A, bottom), the fins regenerated equally as well as WT fins
(Figure 4C). This indicates that ARF inhibits fin regeneration in a reversible manner and that its con-
tinued expression is required for regeneration suppression.
ARF suppresses fin regeneration in a p53-dependent manner by
inducing apoptosis and causing cell-cycle arrest
To assess whether ARF functions through the p53 pathway to inhibit fin regeneration in vivo, we
examined Tp53 protein and transcript levels as well as induction of the p53 target gene cdkn1a
(p21) in response to ARF expression at 4 dpa (Figure 4—figure supplement 1C). The induction and
stabilization of p53 and induction of cdkn1a transcripts by ARF showed that ARF impacts p53 func-
tions in vivo in fish regenerates. To assess the Tp53-dependence of ARF, we first crossed hs:ARF fish
with tp53M214K mutant fish to generate hs:ARF fish that are homozygous for the tp53M214K allele (hs:
ARF; tp53M214K/M214K). The tp53M214K mutation abrogates Tp53 transactivation functions
(Berghmans et al., 2005). Using the same amputation and heat shock regimen, we analyzed fin
regeneration and found no difference in regenerate length or area despite ARF expression in tp53
mutant fish (Figure 5A). We also tested Tp53-dependence of ARF regeneration suppression by
treating zebrafish with either pifithrin-a (PFTaSigma, St. Louis, MO), an inhibitor of Tp53 transactiva-
tion (Komarov et al., 1999), or nutlin3a, a molecule that disrupts the Mdm2–Tp53 interaction,
thereby stabilizing Tp53 levels (Yun et al., 2013; Vassilev et al., 2004). Treatment of hs:ARF and
WT fish with 5 mM PFTa and heat shock increased hs:ARF regenerate length from 0.44 ± 0.04 mm to
0.66 ± 0.08 mm, an increase of 50% (p<0.01), and area from 1.8 ± 0.7 mm2 to 3.2 ± 0.5 mm2, an
increase of approximately 75% (p<0.05), compared with carrier-treated controls. Fin regeneration of
WT fish was not affected by PFTa treatments (Figure 5B). Treatment of WT fish with 5 mM nutlin3a
reduced fin regenerate length from approximately 0.65 ± 0.1 mm to 0.45 ± 0.1 mm, a decrease of
30% (p<0.01), and area from 4.7 ± 1.2 mm2 to 2.8 ± 0.7 mm2, a reduction of 40% (p<0.05)
(Figure 5C, left), phenocopying the fin regeneration inhibition phenotype of induced hs:ARF fish
(Figure 5C, right). Together, these experiments show that ARF functions through Tp53-dependent
mechanisms to inhibit fin regeneration, and also demonstrate the importance of active suppression
of Tp53 by Mdm2.
In order to understand the cellular effects of ARF that lead to inhibition of fin regeneration, we
examined apoptosis and proliferation in blastema cells during regeneration with and without ARF
expression. To estimate cell proliferation differences between WT and hs:ARF fins, EdU pulse-chase
experiments were performed at 2, 4, and 6 dpa. EdU incorporation was significantly higher in WT fin
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regenerates compared with hs:ARF regenerates at all time points examined with the greatest differ-
ence occurring at 2 dpa (171%, p<0.001) (Figure 6A). Apoptotic cells in hs:ARF and WT regenerates
were analyzed using terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining.
When the percent of TUNEL + cells in WT and hs:ARF regenerates was compared, the incidence of
apoptosis increased with ARF expression at all time points examined with the greatest difference
Figure 4. ARF suppresses fin regeneration. (A) Schematic of heat shock regimen. An initial hour long, 37˚C heat
shock is delivered 3 hr prior to amputation (0 dpa) and then every 6 hrs thereafter for 6 days. Regenerates are then
assessed (top) or fins are reamputated (0 dpa) and allowed to regenerate in the absence of heat shock for 6 days
(bottom). (B) Quantification of regenerate length and area at 6 dpa in WT and hs:ARF fins exposed to the heat
shock regimen (left; N = 40 fins representing multiple different transgene insertions, p<0.001). Representative
images of fin regeneration at 6 dpa in WT and hs:ARF fins exposed to the heat shock regimen (right). (C)
Quantification of regenerate length and area at 6 dpa in reamputated hs:ARF fins not exposed to heat shock (left;
N = 40 fins, p>0.05). Representative image of fin regeneration at 6 dpa in a reamputated hs:ARF fin not exposed
to heat shock (right). The dashed lines represent amputation planes. Scale bars: 1 mm. Results are shown as mean
± standard deviation. Figure supplement 1 shows ARF and Tp53 immunostaining at 4 dpa, and tp53 and cdkn1a
expression changes with ARF expression. It also shows regeneration at 14 dpa after heat shock was discontinued
at 6 dpa. hs: Heat shock; WT: Wild type. n.s.: not significant.
DOI: 10.7554/eLife.07702.011
The following figure supplements are available for Figure 4:
Figure supplement 1. ARF expression during regeneration promotes Tp53, tp53, and cdkn1a
upregulation and regeneration inhibition is reversible.
DOI: 10.7554/eLife.07702.012
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Figure 5. Human ARF functions through the Tp53 pathway in fish to suppress regeneration. (A) Quantification of regenerate length and area at 6 dpa
in tp53M214K/M214K, hs:ARF, and hs:ARF; tp53M214K/M214K fins exposed to the heat shock regimen as in Figure 4 (left; N = 30 fins). Representative images
of fin regeneration at 6 dpa in tp53M214K/M214K, hs:ARF, and hs:ARF; tp53M214K/M214K fins exposed to heat shock (right). Scale bars: 1 mm.
Immunostaining (sagittal confocal images) for ARF in tp53M214K/M214K and hs:ARF; tp53M214K/M214K fins 3 hr after a single heat shock (right inset). Scale
bars: 10 mm. Fin regeneration proceeds equally well in tp53M214K/M214K and hs:ARF; tp53M214K/M214K fins exposed to heat shock, but fin regeneration
inhibition is observed in hs:ARF fins exposed to heat shock. (B) Quantification of regenerate length and area at 4 dpa in wild type (WT) and hs:ARF fins
exposed to heat shock and 5 mM pifithrin-a(PFTa) or 0.1% Dimethyl sulfoxide (DMSO) (vehicle) (left; N = 8 fins, p<0.01). Representative images of fin
regeneration at 4 dpa in WT and hs:ARF fins exposed to heat shock and 5 mM PFTa or 0.1% DMSO (right). Scale bars: 0.5 mm. Inhibition of Tp53
Figure 5. continued on next page
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occurring at 2 dpa (210%, p<0.01) (Figure 6B). To assess whether ARF directly affects proliferating
blastema cells, we also measured EdU incorporation with different heat shock regimens starting at 4
dpa. The results showed that either a single heat shock or 24 hr of heat shocks at 4 dpa significantly
reduced the number of cycling cells in the regenerate, demonstrating a direct effect of ARF on the
regenerating cell population (Figure 6C).
ARF does not affect development but suppresses fin regeneration in
response to regeneration signals
Since the ARF promoter is activated specifically in the fin during regeneration, we tested how trans-
genic fish expressing ARF under control of the endogenous ARF promoter would develop and
regenerate. To do so, we generated zebrafish lines from independent transgenic insertions that uti-
lize the human ARF promoter to drive ARF expression (Tg (ARF:ARF) or ARF:ARF) (Figure 7A, left).
ARF expression during development would be expected to adversely affect ARF:ARF fish. We
observed, however, that ARF:ARF transgenic fish are viable, develop normally, and have no overt
size or morphological differences when compared with age- and sex-matched WT counterparts
(Figure 7A, right). Furthermore, examination of ARF:ARF embryos confirmed our findings in ARF:
GFP transgenics. In agreement with the predictions of ARF:GFP experiments, there was no effect of
the ARF:ARF transgene on survival during early embryogenesis compared with WT fish (Figure 7—
figure supplement 1A). We also did not detect ARF expression in embryos, as expected given our
findings with ARF:GFP fish (Figure 7—figure supplement 1A). To assess whether ARF, if expressed,
would interfere with organogenesis or development, we evaluated the effects of induced ARF
expression using hs:ARF fish. Upon heat shock, hs:ARF, but not WT clutches, exhibited drastically
reduced survival that was associated with high levels of ARF expression throughout the embryo (Fig-
ure 7—figure supplement 1B). This finding indicates that ARF expression is very poorly tolerated
by developing embryos and clearly implies that in ARF:ARF fish, ARF is not activated significantly
during development to affect normal developmental growth and organogenesis.
We then performed fin regeneration experiments with ARF:ARF transgenic fish and WT fish.
When ARF:ARF fins were injured, ARF was detected in the regenerate (Figure 7B), and the pattern
of expression was similar to GFP expression in ARF:GFP regenerates at the same time point (Fig-
ure 1). When fin regeneration was compared between ARF:ARF transgenic fish and WT fish, ARF:
ARF regenerates measured 0.55 ± 0.17 mm in length and 1.8 ± 1.3 mm2 in area, while WT regener-
ates measured 1.2 ± 0.06 mm in length and 6.0 ± 1.4 mm2 in area. To rule out position effects of the
transgene insertion, a second independent transgenic ARF:ARF line was also assessed. Regenerates
of this second ARF:ARF line measured 0.6 ± 0.2 mm in length and 2.3 ± 0.96 mm2 in area, while WT
regenerates measured 1.1 ± 0.13 mm in length and 5.1 ± 0.67 mm2 in area. In all, ARF:ARF regener-
ates were 55% (p<0.001) and 44% (p<0.001) shorter and 70% (p<0.001) and 55% (p<0.001) smaller
in area than WT regenerates, and anatomical fin defects persisted 1 month after amputation
(Figure 7C, Figure 7—figure supplement 2). ARF expression persisted in ARF:ARF fins but not WT
fins at 6 dpa (Figure 7—figure supplement 3A), a time point at which GFP in no longer observed in
regenerated ARF:GFP fins, suggesting ongoing regeneration attempts in ARF:ARF fins.
We confirmed that fin regeneration inhibition in ARF:ARF fish was p53 dependent as in hs:ARF
fish. Tp53, tp53, and cdkn1a expression increased with ARF expression in ARF:ARF fins at 4 dpa
(Figure 7—figure supplement 3B). As in hs:ARF fish, treatment of ARF:ARF fins with 5 mM PFTa res-
cued fin regeneration (Figure 7—figure supplement 3C). Finally, we quantified the cell cycle arrest
that is a consequence of ARF expression comparing WT and ARF:ARF fins with EdU pulse-chase
labeling at 2, 4, and 6 dpa. Similar to hs:ARF fins, ARF:ARF fin regenerates had significantly fewer
proliferating cells than WT fin regenerates at all time point assessed with the largest difference
observed at 4 dpa (81%, p<0.001) (Figure 7—figure supplement 3D).
Figure 5. Continued
activity with PFTa rescues regeneration suppression by ARF. (C) Quantification of regenerate length and area at 4 dpa in WT fins exposed to 5 mM
nutlin3a or Ethanol (EtOH) (vehicle) (left; N = 8 fins, p<0.01). Representative images of fin regeneration at 4 dpa in WT fins exposed to 5 mM nutlin3a or
EtOH (right). Scale bars: 0.5 mm. Inhibition of Mdm2 with nutlin3a phenocopies ARF expression by suppressing fin regeneration. The dashed lines
represent amputation planes. Results are shown as mean ± standard deviation. n.s.: not significant.
DOI: 10.7554/eLife.07702.013
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Figure 6. ARF suppresses fin regeneration by inducing apoptosis and cell-cycle arrest. (A) Quantification of EdU
staining at 2, 4, and 6 dpa in wild type (WT) and hs:ARF fins exposed to heat shock (left). At 2 dpa, 6.0% ± 1.1% of
cells in WT regenerates were EdU + compared with approximately 2.2% ± 0.8% in Heat shock (hs):ARF
regenerates. At 4 dpa, approximately 7.4% ± 0.6% of cells in WT regenerates were EdU + compared with 4.2% ±
0.6% in hs:ARF regenerates. At 6 dpa, approximately 6.4% ± 0.9% of cells in WT regenerates were EdU +
compared with 2.7% ± 0.3% in hs:ARF regenerates. Significantly fewer cycling cells are detected with ARF
expression (N = 10 fins, p<0.001). Representative (left – sagittal confocal, right – longitudinal) images of EdU
staining at 2 dpa in WT and hs:ARF fins exposed to heat shock (right). Scale bars: left – 50 mm, right – 25 mm.
Dashed lines represent amputation planes. (B) Quantification of Terminal deoxynucleotidyl transferase dUTP nick
end labeling (TUNEL) staining at 2, 4, and 6 dpa in WT and hs:ARF fins exposed to heat shock (left). At 2 dpa,
2.2% ± 1.2% of cells in WT regenerates were TUNEL + , while 6.7% ± 3.7% of cells in hs:ARF regenerates were
TUNEL + . At 4 dpa, only 2.7% ± 1.2% of cells in WT regenerates were TUNEL + compared with 4.8% ± 0.8% in hs:
ARF regenerates. At 6 dpa, 2.4% ± 0.6% of cells in WT regenerates were TUNEL +, while 3.1% ± 0.5% of cell in hs:
ARF regenerates were TUNEL +. Significantly more apoptosis is detected with ARF expression (N = 10 fins,
p<0.001). Representative images (left – sagittal, right – longitudinal) of TUNEL staining at 2 dpa in WT and hs:ARF
fins exposed to heat shock (right). Image quantification was performed on regenerates only. Dashed lines
represent amputation planes. Scale bars: left – 50 mm, right – 25 mm. (C) Quantification of EdU staining in WT and
hs:ARF fins 3 hr after a single heat shock or 24 hr of heat shock delivered at 4 dpa. After a single heat shock, 3.3%
± 1.5% of cells in WT regenerates were EdU + compared with 1.9% ± 0.6% in hs:ARF regenerates. After 24 hr of
heat shock, 3.0% ± 0.7% of cells in WT regenerates were EdU + compared with 1.2% ± 0.4% in hs:ARF
regenerates. Significantly fewer cycling cells are detected with ARF expression after blastema formation (N = 10
fins, p<0.001). Results are shown as mean ± standard deviation.
DOI: 10.7554/eLife.07702.014
Hesse et al. eLife 2015;4:e07702. DOI: 10.7554/eLife.07702 13 of 23
Research article Developmental biology and stem cells Genes and chromosomes
Figure 7. ARF senses regenerative signals and suppresses fin regeneration. (A) Schematic of transgene
expressing human ARF under the control of the human ARF promoter (left). Representative images of age- and
sex-matched ARF:ARF and WT zebrafish (right; 5 months postfertilization, male). Scale bar: 1 cm. ARF:ARF fish are
viable, grow to adulthood and are of normal size and patterning. (B) Immunostaining (longitudinal confocal
images) for ARF in ARF:ARF transgenic fish before injury (uninjured ) and at 2 dpa. Scale bars: 50 mm. ARF is
specifically expressed upon injury. The dashed line represents the amputation plane. (C) Representative images of
fin regeneration at 6 dpa in WT and ARF:ARF fins (top). Scale bars: 1 mm. The dashed lines represent amputation
planes. Quantification of regenerate length and area at 6 dpa in WT and ARF:ARF fins (bottom; N= 10 fins,
p<0.001). The first set of bars in each graph represents the results from one transgenic line (Line 1), while the
second set of bars represents the results from a second, independent transgenic line (Line 2). ARF causes marked
inhibition of fin regeneration. Results are shown as mean ± standard deviation. Figure supplement 1 shows the
embryonic viability of ARF transgenic lines. Figure supplement 2 shows the failure of ARF:ARF fins to completely
regenerate after 15 days and even 30 days. Figure supplement 3 shows ARF immunostaining at 6 dpa, Tp53, tp53,
Figure 7. continued on next page
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These results confirm that ARF activation is specific to regenerating tissue and show that the
magnitude of activation is sufficient to inhibit regeneration. Thus, the presence of a functional human
ARF gene in fish results in a diminished regenerative capacity, including absence of epimorphic
regeneration, without significantly affecting other major physiological or developmental
characteristics.
Discussion
In this study, we have experimentally tested the hypothesis that tumor suppressor evolution may
impact regenerative capacity. We found that the core mammalian tumor suppressor ARF senses
regeneration signals and specifically responds to negatively alter the proliferative balance in the
zebrafish blastema, greatly perturbing regeneration. Our findings provide the first in vivo experimen-
tal evidence that evolution of tumor suppressors can negatively impact solid tissue regeneration
potential.
Although the core tumor suppressors as a whole support regenerative processes, the properties
of ARF identified in this study are at odds with epimorphic regeneration. This new example of antag-
onistic pleiotropy adds to previously recognized trade-off characteristics of tumor suppressor genes
affecting mammalian stem cell function (Pardal et al., 2005; Greaves, 2007; Pomerantz and Blau,
2013; Rodier et al., 2007) and shows that ARF antagonistic properties also manifest in the context
of the blastema. The evidence that ARF is a critical tumor suppressor in mammals (Sherr, 2006,
Sharpless, 2005), but opposes regeneration functions (Sharpless and DePinho, 2007), suggests
that the selective pressure that has driven the evolution of ARF has primarily enhanced tumor sup-
pression either at the expense of or in the absence of regeneration pressures. Although our experi-
ments and those of others (Gemberling et al., 2013; Poss et al., 2003) show that the regenerative
capacity of zebrafish is vulnerable to single gene alterations, whether altering function of a single
gene in mammals would induce the emergence of robust epimorphic regenerative capacity is a
much more complex issue. Indeed, the multifactorial genetic differences of highly and less regenera-
tive vertebrates make it unlikely that manipulation of a single gene could enable regeneration. It is
notable, however, that Cdkn1a (p21) knockout mice do possess a somewhat enhanced ability to
regenerate solid structures (Heber-Katz et al., 2013; Clark et al., 1998) such as pinnae, which lack
the complex tissue structure of a digit, but nonetheless, demonstrate that alteration of cellular
growth control mechanisms can impact regeneration. Moreover, the importance of active repression
of ARF to maintain stem cell function (Molofsky et al., 2005), and of ARF reduction to facilitate
dedifferentiation (Pajcini et al., 2010) have been documented.
Among the core tumor suppressor genes that are frequently inactivated in mammalian tumors,
ARF is unique in that it does not have orthologs represented in most vertebrates including highly
regenerative species. By contrast, Tp53, Pten, and Ink4a have distant orthologs, present in inverte-
brates and vertebrates alike. The transgenesis approach we used to study ARF in fin regeneration
made it possible for us to study ARF with its human regulatory components but without increasing
CDKN2A CKI gene dosage, which could have been a complicating factor in a transgenic harboring
the entire CDKN2A (INK4A/ARF) locus. This study extends our previous observations (Pajcini et al.,
Figure 7. Continued
and cdkn1a expression changes with ARF expression in WT and ARF:ARF fins at 4 dpa, fin regeneration rescue in
ARF:ARF fins treated with PFTa, and EdU incorporation studies performed in WT and ARF:ARF fins. TSS:
Transcriptional state site; uninj.: Uninjured; WT: Wild type. n.s.: not significant.
DOI: 10.7554/eLife.07702.015
The following figure supplements are available for Figure 7:
Figure supplement 1. The ARF:ARF transgene does not interfere with development, whereas forced ARF
expression causes embryonic lethality.
DOI: 10.7554/eLife.07702.016
Figure supplement 2. ARF:ARF fins do not completely regenerate even after 30 days.
DOI: 10.7554/eLife.07702.017
Figure supplement 3. ARF:ARF expression and p53-dependent functions during regeneration.
DOI: 10.7554/eLife.07702.018
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2010) that ARF prevents dedifferentiation in muscle cells in culture and provides new evidence that
ARF functions in vivo to oppose tissue regeneration. Future experiments will determine whether
ARF prevents dedifferentiation in vivo, such as the dedifferentiation of osteoblasts in regenerating
fins, or whether it acts on proliferating blastema cells after they have dedifferentiated. Combined,
our findings suggest that zebrafish cells are more promiscuous in terms of tolerance to high levels of
mitogenic activity, thus permitting the cellular processes required for epimorphic regeneration. It fol-
lows that regenerating cells in organisms that have an ARF gene would need to prevent ARF activa-
tion or would be inherently more restricted in these activities.
We found that ARF recapitulates its core mammalian mechanistic functions in zebrafish cells and
tissues. As in mammals, when ARF is overexpressed in zebrafish cells, it associates with Mdm2, sta-
bilizes Tp53, and induces cell cycle arrest or apoptosis. This functional conservation over an evolu-
tionary distance demonstrates that cross-species genetic variations can be experimentally examined
in the study of regeneration. When ARF expression is driven by its endogenous human promoter in
zebrafish cells, activation of the p53 axis occurs specifically in the blastema-regeneration scenario.
Remarkably, the inhibitory effect on regeneration by ARF:ARF was stronger than with the heat shock
promoter, probably reflecting ongoing surveillance of regenerative signals by the ARF promoter in
contrast to fluctuating ARF levels obtained with intermittent heat shock induction of a short half-life
protein. In the developing or adult uninjured state, E2f1 is sequestered and inhibited by Rb1, and
ARF is inactive. However, during blastema formation and regeneration, Rb1 hyperphosphorylation is
associated with sufficient free E2f1 to activate ARF, which inhibits fin regeneration via a Tp53-depen-
dent mechanism (Figure 8). Our findings and model are in agreement with the recent proposal that
in salamanders the absence of ARF permits downregulation of Tp53 during blastema formation
(Yun et al., 2013). The responsiveness of ARF to the Rb pathway proliferative signaling characteristic
of zebrafish fin regeneration implies that similar mitogenic signaling occurring in a mammalian con-
text would be detected as aberrant, activate ARF–MDM2–TP53 tumor suppressor mechanisms, and
Figure 8. Model of ARF function in the context of Rb pathway activity during zebrafish development and fin
regeneration. ARF is not active during development during which a moderate level of mitogenic signaling causes
modest phosphorylation of Rb1 (top); however, during regeneration, high mitogenic signaling induces Rb1
hyperphosphorylation and abundant free E2f1, which activates ARF and leads to inhibition of regeneration
(bottom). The dashed lines represent the amputation plane.
DOI: 10.7554/eLife.07702.019
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oppose regeneration. Our findings are compatible with previous mouse studies showing that ARF is
a potent tumor suppressor that is dispensable for normal development (Serrano et al., 1996;
Kamijo et al., 1997). Moreover, prior observations that ARF is not developmentally expressed in the
majority of tissues in the mouse (Gromley et al., 2009; Zindy et al., 2003) support the fidelity of
the promoter used in this study. Although the majority of tumor suppressors probably function in
regeneration as they do in normal development, the findings of the present study indicate that ARF
represents an unusual departure from that paradigm in that the properties that cause it to respond
specifically to tumorigenesis also cause it to distinguish regeneration contexts from developmental
ones.
We show here how examination of zebrafish that are humanized with respect to candidate regen-
eration modifiers is informative for understanding disparate regenerative capacities. Such an
approach should prove useful for examining other candidate genes and pathways of interest. Our
findings with respect to ARF strongly suggest that it is a barrier to mammalian epimorphic regenera-
tion because it interprets the regeneration context as similar to tumorigenesis. It follows conceptu-
ally that approaches to induce epimorphic regeneration clinically would need to disrupt ARF–
MDM2–TP53 axis activation.
Materials and methods
Zebrafish
Zebrafish maintenance at 28–30˚C and all experiments were approved by the Institutional Animal
Care and Use Committee of the University of California, San Francisco. Three- to six-month-old WT
or transgenic AB zebrafish were used for all experiments. The Tg (hsp70l:ARF), Tg (ARF:ARF), and
Tg (ARF:GFP) constructs were created by either subcloning the cDNA of human ARF (exons 1b, 2,
and 3 of CDKN2A) or a cytoplasmic EGFP cassette downstream of either the promoter sequences of
zebrafish hsp70l (Halloran et al., 2000) or the human CDKN2A promoter (Robertson and Jones,
1998), respectively. The ARF promoter was subcloned from pKR19 (Robertson and Jones, 1998)
using SalI to excise an approximately 1 kb region of the human promoter, which encompassed 736
bp 50 of the transcriptional state site of ARF. Sequence information can be found in del Arroyo
et al. (2007). Tol2-mediated transgenesis was used to generate transgenic animals (Kwan et al.,
2007). Transgenic animals were detected based on their GFP-positive hearts, due to the transgenes
containing a cmlc2:GFP cassette. All transgenic strains were analyzed as hemizygotes. For drug
treatment experiments, zebrafish were treated with 5 mM aPTFa in dimethyl sulfoxide (DMSO)
(5 mM stock) or 5 mM (-)-Nutlin-3 (Cayman, Ann Arbor, MI) in ethanol (EtOH) (5 mM stock). Water
was exchanged daily. For EdU pulse-chase experiments, 5 mL of 5 mg/mL of EdU (Life Technologies,
Carlsbad, CA) in saline was injected intraperitoneally into anesthetized fish 30 min before tissue
harvest.
Immunostaining
Zebrafish fin immunostaining was performed on whole-mounted fins as previously described
(Sousa et al., 2011). For coronal views, whole-mount stained fins were embedded in 5% agarose,
and 200 mm sections were cut with a vibratome. Imaging was performed with a confocal microscope.
Zebrafish embryo immunostaining was performed on whole-mounted, 1-phenyl 2-thiourea (PTU;
Sigma)-treated embryos as previously described (Macdonald, 1999). Zebrafish cell immunostaining:
4% paraformaldehyde (PFA) 10 min, phosphate-buffered saline (PBS) 5 min 3, 0.3% PBTx 15 min,
PBS 5 min 3, serum-free protein block (Dako, Carpinteria, CA) 1 hr, primary antibodies in antibody
diluent (Dako) overnight 4˚C, PBS 5 min 3, secondary antibodies in antibody diluent 1 hr, PBS 5
min 3, mounted with Vectashield mounting medium with DAPI (Vector Laboratories, Burlingame,
CA). EdU incorporation was detected using the Click-iT EdU Imaging Kit per the manufacturer’s
instructions (Life Technologies). TUNEL detection was performed using the In Situ Cell Death Detec-
tion Kit (Roche, Basel, Switzerland) per the manufacturer’s instructions. Images were quantified in
ImageJ. The percent of EdU + or TUNEL + cells was quantified by first counting the number of posi-
tive cells in the regenerate and then dividing that count by the number of nuclei in the field counted.
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In situ hybridization
Zebrafish embryo mRNA in situ hybridization was performed on whole-mounted, PTU-treated
embryos as previously described (Chitramuthu and Bennett, 2013). The antisense GFP probe was
labeled with digoxigenin-11-UTP (Roche) and generated using the following primers: 50-AAGGGC-
GAGGAGCTGTTCAC-30 and 50-GAACTCCAGCAGGACCATGT-30 (MacDonald et al., 2010).
Western blot
An amount of 50–60 mg of total protein isolated from adult zebrafish fin tissue was loaded per lane,
electrophoresed, and transferred to polyvinyl difluoride (PVDF) membranes. Protein was visualized
using ECL Prime (GE Healthcare Bio-Sciences, Pittsburgh, PA) and an ImageQuant LAS 4000 (GE
Healthcare Bio-Sciences). Band quantification was performed using ImageQuantTL software. For
each condition, Rb1 and p-Rb1 bands were normalized to b-Actin, and the ratio of p-Rb1:Rb1 was
calculated and made relative to uninjured tissue (Table 1).
Fin regeneration and wounding
Caudal fin amputations were performed with a razor blade on fish anesthetized with 0.016% tricaine
in aquarium water; consistently only the distal halves of fins were amputated. Heat shocks were
delivered by housing fish in a water bath set to 37˚C with bidiurnal water exchanges. The water bath
achieved 37˚C within 15 min, maintained that temperature for 1 hr, and then passively cooled to fish
room temperature (26–28˚C). An automatic digital timer (Intermatic, Spring Grove, IL) was used to
turn on and off the water bath. For heat shock experiments, an initial heat shock was delivered and
then fins were amputated 3 hr later. Heat shocks were subsequently delivered every 6 hrs for the
duration of the experiment. Quantification of fin regenerate length, area, and GFP intensity was per-
formed in ImageJ. Fin regenerate length was calculated by averaging the length of the longest dor-
sal and ventral fin ray from the amputation plane. Caudal fin wounding experiments were performed
as previously described (Gauron et al., 2013).
ChIP
ChIP of zebrafish fin tissue was performed as previously described (Wehner et al., 2014) with a Bio-
ruptor UCD-200 (Diagenode, Denville, NJ) at high power for six 5-min cycles of 30 s ON, 30 s OFF;
water was changed after each cycle; 5 mg of rabbit anti-E2f1 antibody or rabbit IgG (Vector Labora-
tories) was used.
Promoter annotation was performed by first identifying the sequences amplified by each primer
set (Table 2) using the Ensembl Genome Browser and then inputting those sequences into Tfsites-
can (http://www.ifti.org/). E2f binding sites were identified and highlighted in bold (Figure 2—figure
supplement 1).
Table 1. Primary antibodies.
Host species Antigen Company Cat. No. Dilution Application
Mouse Tp53 Abcam ab77813 1:50 IHC
Rabbit Mdm2 Santa Cruz C-18 1:50 IHC
Rabbit GFP Torrey Pines TP401 1:3000 IHC
Chicken GFP Abcam ab13970 1:3000 IHC
Mouse Msxb DSHC 4G1-c 1:50 IHC
Rabbit PCNA Abcam ab2426 1:500 IHC
Mouse p14ARF Cell Signaling 2407 1:100/1:500 IHC/WB
Rabbit Rb1 AnaSpec 55432 1:500 WB
Rabbit p-Rb1 (S780) Abcam ab47763 1:500 WB
Rabbit Beta-actin Millipore EP1123Y 1:1000 WB
Rabbit E2f1 Abcam ab14769 1:1000 WB
IHC: Immunohistochemistry; PCNA: Proliferating cell nuclear antigen; WB: Western blot.
DOI: 10.7554/eLife.07702.020
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Gene quantification
qPCR assays were performed on 100 ng of cDNA using 1 mL of each primer (10 pmol/mL) and iTaq
Universal SYBR Green Supermix (Bio-Rad, Hercules, CA, United States) in a 12 mL total reaction vol-
ume (Table 3). The PCR was performed for 40 cycles with annealing temperatures of 58–60˚C and
elongation times of 1 min. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Netherlands)
per the manufacturer’s instructions. cDNA was prepared from total RNA using random hexamer pri-
mers and the SuperScript III First Stand Synthesis System for reverse transcription-PCR (Life Technol-
ogies) per the manufacturer’s instructions. Primers used to quantify tp53 and cdkn1a expression
levels have been previously described (Danilova et al., 2014).
Cell culture
Zebrafish cells were cultured at 32˚C, 5% CO2 in Dulbecco’s Modified Eagle Medium: Nutrient Mix-
ture F-12 (DMEM:F-12) medium (ATCC, Manassas, VA) with 10% fetal bovine serum (FBS), 1% peni-
cillin/streptomycin (Pen/Strep) (ZF4), or 50% L-15, 35% DMEM, 15% Ham’s F-12 medium with 1.8
mM NaHCO3, 15 mM HEPES, 1% Pen/Strep, 10% FBS, 1% l-glutamine, 0.2% gentamicinsulfate
(ZKS). HeLa cells were grown at 37˚C, 5% CO2 in DMEM with 10% FBS, 1% Pen/Strep. The pcDNA-
ARF construct was created by subcloning the cDNA of human ARF (exons 1b, 2, and 3 of CDKN2A)
into the multiple cloning site of pcDNA3.1(+). Cells were transfected with either pcDNA-ARF or an
empty vector (pcDNA). Transient transfections were performed using the FuGENE 6 transfection
reagent (Promega, Madison, WI) according to the manufacturer’s instructions. Cells were analyzed 2
days posttransfection. Luciferase assays were performed with pGL3-ARF-736 bp and pGL3-ARF-
3.4 kb as previously described (del Arroyo et al., 2007) without activator DNA.
Statistical analysis
Data are presented as mean ± standard deviation. Statistical analyses were performed by using SPSS
Statistics Desktop, version 22.0 (IBM, Armonk, NY). Statistical differences were analyzed by using a
Student’s t-test. A p<0.05 was set as the threshold for statistical significance.
Table 2. Chromatin immunoprecipitation primers.
Gene Ensembl ID Target site Forward primer Reverse primer
CDKN2A ENSG00000147889 TSS 50-GCTGAGGGTGGGAAGATG-30 50-CCTTAACTGC
AGACTGGGA-30
tk1 ENSDARG00000086561 TSS 50-AGTCACTGTGCCGGTTTATT-30 50-GTCGTCTGCTTG
TTGTCTTTATTT-30
tk1- ENSDARG00000086561 2 kbp 50
of TSS
50-CAGGCTTACGGAGACAGCAA-30 50-AGTGTTTGCTG
CTGGATCAC-30
TSS: Transcriptional state site.
DOI: 10.7554/eLife.07702.021
Table 3. Quantitative polymerase chain reactionprimers.
Gene RefSeq ID Forward primer Reverse primer
CDKN2A NM_058195.3 50-ATGGTGCGCAGGTTCTTGGTGA-30 50-CACCACCAGCGTGT
CCAGGAAG-30
actb2 NM_181601.4 50-CGAGCAGGAGATGGGAACC-30 50-CAACGGAAACGCT
CATTGC-30
tp53 NM_131327.2 50-CTGAAGTGGTCCGCAGATG-30 50-CGTTTGGTCCCAG
TGGTGG-30
cdkn1a NM_001128420.1 50-AGCTGCATTCGTCTCGTAGC-30 50-TGAGAACTTACT
GGCAGCTTCA-30
DOI: 10.7554/eLife.07702.022
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